News Quantified

RCUS – arcus biosciences, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Arcus Biosciences (RCUS) had its price target raised by Citigroup Inc. from $44.00 to $45.00. They now have a "buy" rating on the stock.

Arcus Biosciences (RCUS) had its price target raised by Leerink Partners from $36.00 to $49.00. They now have an "outperform" rating on the stock.

Arcus Biosciences (RCUS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.

Arcus Biosciences Puts Casdatifan Kidney Cancer Data At Center Stage [Yahoo! Finance]

Arcus Biosciences Q4 Earnings Call Highlights [Yahoo! Finance]

-3.6%

BEAT

-2.2%

BEAT

-1.4%

MISS

Leerink Partners

Wells Fargo & Company

Form S-3ASR Arcus Biosciences, Inc.

Form S-8 Arcus Biosciences, Inc.

Form 10-K Arcus Biosciences, Inc. For: Dec 31

Form 8-K Arcus Biosciences, Inc. For: Feb 25

Form 4 Arcus Biosciences, Inc. For: Jan 23 Filed by: ROSEN TERRY J

Top News Gainers

9/26 Arcus Biosciences Inc (NYSE: RCUS) is now covered by analysts at Mizuho. They set a "buy" rating on the stock. 15.6%

2/18 Arcus Biosciences Inc (NYSE: RCUS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 12.7%

8/8 Arcus Biosciences Inc (NYSE: RCUS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 11.0%

3/4 Arcus Biosciences Inc (NYSE: RCUS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $24.00 price target on the stock. 7.7%

6/11 Arcus Biosciences to Provide a Mid-Year Update on Clinical and Preclinical Programs 6.4%

11/12 Arcus Biosciences Inc (NYSE: RCUS) is now covered by analysts at SunTrust Banks, Inc.. They set a "buy" rating on the stock. 5.4%

4/9 Arcus Biosciences Announces New Employment Inducement Grants 5.3%

12/18 Arcus Biosciences, in Collaboration with Genentech, Announces Two Randomized Clinical Studies to Advance AB928, a Dual Adenosine Receptor Antagonist, into Novel Combinations for Colorectal and Pancreatic Cancers 4.9%

10/30 Form 4 Arcus Biosciences, Inc. For: Oct 28 Filed by: Ribas Antoni 4.5%

7/4 Arcus Biosciences Inc (NYSE: RCUS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock. 4.4%

Top News Decliners

3/14 Arcus Biosciences Inc (NYSE: RCUS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -24.3%

2/25 Arcus Biosciences Inc (NYSE: RCUS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -9.5%

11/25 Form 8-K/A Arcus Biosciences, Inc. For: Sep 10 -8.8%

4/7 Form 8-K Arcus Biosciences, Inc. For: Apr 07 -7.6%

11/7 Arcus Biosciences Inc (NYSE: RCUS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.3%

10/4 Form 3 Arcus Biosciences, Inc. For: Oct 01 Filed by: Barker Jason -6.7%

4/16 Arcus stock jumps on Bloomberg News report that Gilead may take a stake [MarketWatch] -6.3%

3/3 Arcus Biosciences Inc (NYSE: RCUS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -5.3%

2/22 3 Biotech Stocks That Soared This Week: Are They Buys? [The Motley Fool] -5.1%

2/26 Arcus Biosciences Inc (NYSE: RCUS) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $22.00 price target on the stock. -4.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day